We came across a bullish thesis on Johnson & Johnson (NYSE:JNJ) on Business Model Mastery Substack by The Antifragile ...

Johnson Matthey has entered the public spat brewing over an activist campaign from its largest investor, attempting to ...

Andrew Curtin said his wife's death after being diagnosed with mesothelioma was a result of using the company's talc-based ...

Johnson & Johnson (NYSE:JNJ – Get Free Report) was the target of a significant decrease in short interest in the month of December. As of December 15th, there was short interest totalling 17,570,000 ...

The Zacks Large Cap Pharmaceuticals industry, to which Johnson & Johnson belongs, has lost 2.5% over this period. Now the key question is: Where could the stock be headed in the near term? While media ...

The announcement marks the next step in Johnson & Johnson’s South African journey. Under a single umbrella, the company plans to further leverage its expertise in innovative medicine and medical ...

One of the biggest beefs in Hollywood briefly returned to the spotlight at Sunday's Golden Globes. While presenting at the ...